INTEGRATED MODELING OF PROTEIN AND MEMBRANE TRAFFIC IN THE SECRETORY PATHWAY
分泌途径中蛋白质和膜运输的集成建模
基本信息
- 批准号:8248697
- 负责人:
- 金额:$ 19.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-07-01 至 2014-03-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAnimalsAreaBiologicalCell membraneCell physiologyCellsCholesterolCholesterol EstersCholesterol HomeostasisComplexComputer SimulationConflict (Psychology)Cystic FibrosisDataDependenceDiseaseDrug Delivery SystemsEndocytosisEndocytosis PathwayEndoplasmic ReticulumEnzymesFoundationsFundingGlycerophospholipidsGoalsGolgi ApparatusHeadHormonesHumanHuman bodyInsulinIntracellular MembranesKineticsLaboratoriesLeptinLifeLiteratureMediatingMembraneMembrane Protein TrafficMembrane ProteinsModelingPathway interactionsPeptidesProtein Export PathwayProteinsPublishingRecyclingRegulationResearchRetrievalRewardsRiskRoleScientistSeriesSiteSphingolipidsSterol O-AcyltransferaseSterolsSystemSystems BiologyTest ResultTestingTimeTravelVesicleWorkbasecellular imagingcholesterol controlcholesterol traffickingdesignlate endosomelipid metabolismlipid transfer proteinlipid transportmodel developmentprotein transportpublic health relevanceresearch studytheoriestooltrafficking
项目摘要
DESCRIPTION (provided by applicant): In human cells, all membrane proteins (which include many if not most drug targets) and all peptide and protein hormones (including insulin and leptin) travel through the endomembrane system from the place where they are made in the cell to the place where they do their work. Diseases thought to involve the endomembrane system include Alzheimer's dementia, cystic fibrosis, and several diseases of fat and cholesterol metabolism. The endomembrane system itself consists of 3 major parts: the endoplasmic reticulum (ER), the Golgi apparatus and the plasma membrane, plus a complex series of internalization and recycling pathways grouped under the general heading of endocytosis. The long term goal of this research is to build a computer model of the secretory pathway and the endocytosis system that has been successfully tested against experimental results, and can be used to make new predictions. Our short-term goal is to test the possible roles of cholesterol in controlling the endomembrane system. By combining the live-cell imaging of fluorescent proteins and cholesterol with systems biology and kinetic modeling we will test the hypothesis that cholesterol-driven membrane partitioning is the organizing principle of the endomembrane system. The focus will be on testing this idea in four specific areas: 1) cholesterol-regulation of protein export from the endoplasmic reticulum, 2) determining whether the Golgi apparatus or lipid transfer proteins carry cholesterol from the ER to the plasma membrane, 3) cholesterol driven partitioning in the Golgi apparatus, and 4) cholesterol trafficking pathways in endocytosis. Because the goal is an integrated model of these important cell processes, the model will also be tested against key experimental results from other laboratories world-wide.
PUBLIC HEALTH RELEVANCE: Proteins are responsible for making the human body work. More than half of our proteins could not get to the place where they do their work without the "secretory pathway." Diseases of the secretory pathway include Alzheimer's dementia, cystic fibrosis and several diseases of fat metabolism. The goal of our project is to discover how the secretory pathway works by using computer modeling to combine results from many scientists.
描述(由申请人提供):在人类细胞中,所有膜蛋白(包括许多(如果不是大多数)药物靶点)以及所有肽和蛋白质激素(包括胰岛素和瘦素)通过内膜系统从细胞中产生它们的地方到达它们发挥作用的地方。人们认为与内膜系统有关的疾病包括阿尔茨海默氏痴呆、囊性纤维化以及几种脂肪和胆固醇代谢疾病。内膜系统本身由 3 个主要部分组成:内质网 (ER)、高尔基体和质膜,以及一系列复杂的内化和再循环途径,这些途径归入内吞作用的总标题下。这项研究的长期目标是建立分泌途径和内吞系统的计算机模型,该模型已根据实验结果成功进行了测试,可用于做出新的预测。我们的短期目标是测试胆固醇在控制内膜系统中的可能作用。通过将荧光蛋白和胆固醇的活细胞成像与系统生物学和动力学模型相结合,我们将检验胆固醇驱动的膜分配是内膜系统的组织原理的假设。重点将在四个特定领域测试这一想法:1)内质网蛋白质输出的胆固醇调节,2)确定高尔基体或脂质转运蛋白是否将胆固醇从内质网携带到质膜,3)高尔基体中胆固醇驱动的分配,以及4)内吞作用中的胆固醇运输途径。由于我们的目标是建立这些重要细胞过程的集成模型,因此该模型还将根据世界各地其他实验室的关键实验结果进行测试。
公共健康相关性:蛋白质负责人体的运作。如果没有“分泌途径”,我们一半以上的蛋白质就无法到达它们发挥作用的地方。分泌途径疾病包括阿尔茨海默氏痴呆、囊性纤维化和多种脂肪代谢疾病。我们项目的目标是通过使用计算机建模结合许多科学家的结果来发现分泌途径是如何工作的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert Phair其他文献
Robert Phair的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert Phair', 18)}}的其他基金
INTEGRATED MODELING OF PROTEIN AND MEMBRANE TRAFFIC IN THE SECRETORY PATHWAY
分泌途径中蛋白质和膜运输的集成建模
- 批准号:
8452091 - 财政年份:2007
- 资助金额:
$ 19.97万 - 项目类别:
INTEGRATED MODELING OF PROTEIN AND MEMBRANE TRAFFIC IN THE SECRETORY PATHWAY
分泌途径中蛋白质和膜运输的集成建模
- 批准号:
7448579 - 财政年份:2007
- 资助金额:
$ 19.97万 - 项目类别:
INTEGRATED MODELING OF PROTEIN AND MEMBRANE TRAFFIC IN THE SECRETORY PATHWAY
分泌途径中蛋白质和膜运输的集成建模
- 批准号:
7886981 - 财政年份:2007
- 资助金额:
$ 19.97万 - 项目类别:
INTEGRATED MODELING OF PROTEIN AND MEMBRANE TRAFFIC IN THE SECRETORY PATHWAY
分泌途径中蛋白质和膜运输的集成建模
- 批准号:
8051641 - 财政年份:2007
- 资助金额:
$ 19.97万 - 项目类别:
INTEGRATED MODELING OF PROTEIN AND MEMBRANE TRAFFIC IN THE SECRETORY PATHWAY
分泌途径中蛋白质和膜运输的集成建模
- 批准号:
7316731 - 财政年份:2007
- 资助金额:
$ 19.97万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 19.97万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 19.97万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 19.97万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 19.97万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 19.97万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 19.97万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 19.97万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 19.97万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 19.97万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 19.97万 - 项目类别: